In a bid to combat the monkeypox outbreak, U.S. health officials have begun distributing doses of the Jynneos vaccine, which has been approved for use in the United States. The Centers for Disease Control and Prevention (CDC) announced on Monday that over 1,000 doses of the vaccine are being released. Monkeypox is a rare viral disease similar to smallpox, but with milder symptoms. It is primarily found in central and West African countries. By distributing the Jynneos vaccine, health officials hope to contain and prevent further spread of the virus within the affected areas. This move demonstrates the proactive stance taken by experts in response to public health emergencies. For more information about monkeypox and the importance of vaccination, visit the Centers for Disease Control and Prevention website.
